LI Han-yu, LIU Zhe, SUN Wei-wei, et al. Meta-analysis of Chinese herbal medicines for improving IVF-ET outcome in patients with endometriosis. [J]. Beijing Journal of Traditional Chinese Medicine 40(10):1138-1142(2021)
DOI:
LI Han-yu, LIU Zhe, SUN Wei-wei, et al. Meta-analysis of Chinese herbal medicines for improving IVF-ET outcome in patients with endometriosis. [J]. Beijing Journal of Traditional Chinese Medicine 40(10):1138-1142(2021) DOI: 10.16025/j.1674-1307.2021.10.024.
Meta-analysis of Chinese herbal medicines for improving IVF-ET outcome in patients with endometriosis
摘要
目的评价中药对子宫内膜异位症患者体外受精-胚胎移植(IVF-ET)结局的改善作用。方法应用计算机检索CNKI、维普、万方、PubMed、Ovid、Cochrane Library和Web of Science等数据库,纳入中药联合IVF-ET治疗子宫内膜异位症不孕的随机对照试验(RCT),由2名研究者按照Cochrane Handbook Version 5.1.0标准对文献质量进行独立评价,并对数据进行提取并交叉检验,通过RevMan 5.3软件进行Meta分析。结果共纳入10个研究,合计953例患者,文献整体质量一般。Meta分析结果显示中药联合IVF-ET可提高子宫内膜异位症患者临床妊娠率[RR=1.59,95%CI(1.37,1.84)]、取卵数[MD=1.71,95%CI(0.38,3.05)]、受精率[MD=0.11,95%CI(0.07,0.14)]、优质胚胎率[MD=0.13,95%CI(0.11,0.15)]。结论中药联合IVF-ET能有效提高子宫内膜异位症患者的临床妊娠率和胚胎质量。限于纳入文献的质量及数量,上述结论仍需开展更多高质量的研究进一步验证。
Abstract
目的评价中药对子宫内膜异位症患者体外受精-胚胎移植(IVF-ET)结局的改善作用。方法应用计算机检索CNKI、维普、万方、PubMed、Ovid、Cochrane Library和Web of Science等数据库,纳入中药联合IVF-ET治疗子宫内膜异位症不孕的随机对照试验(RCT),由2名研究者按照Cochrane Handbook Version 5.1.0标准对文献质量进行独立评价,并对数据进行提取并交叉检验,通过RevMan 5.3软件进行Meta分析。结果共纳入10个研究,合计953例患者,文献整体质量一般。Meta分析结果显示中药联合IVF-ET可提高子宫内膜异位症患者临床妊娠率[RR=1.59,95%CI(1.37,1.84)]、取卵数[MD=1.71,95%CI(0.38,3.05)]、受精率[MD=0.11,95%CI(0.07,0.14)]、优质胚胎率[MD=0.13,95%CI(0.11,0.15)]。结论中药联合IVF-ET能有效提高子宫内膜异位症患者的临床妊娠率和胚胎质量。限于纳入文献的质量及数量,上述结论仍需开展更多高质量的研究进一步验证。
Meta-analysis of traditional Chinese medicine combined with ranibizumab in the treatment of wet age-related macular degeneration
Meta-analysis of the disease activity of Traditional Chinese Medicine in improving Ankylosing Spondylitis
Meta analysis of a randomized controlled trial of Chinese herbal medicine combined with moxibustion in the treatment of diarrhea type irritable bowel syndrome
中西医结合治疗特发性肺间质纤维化疗效Meta分析
Meta analysis of Xueshuantong incombination with Edaravone for the treatment of acute cerebral infarction